PMC4539555_01
The patient's FT4 levels peaked on post-operative day 3. Reference values are the following: free thyroxine (FT4): 9.1-23.8 pmol/L.
fendo-06-00123-g001.jpg
PMC4539555_01_fendo-06-00123-g001.jpg
F1
A dual-phase PTH scan revealed two foci located below the lower poles of both thyroid lobes with intact thyroid uptake compatible with PTH adenomas (Figure 1).
The patient's TSH levels following surgery. Reference values are the following: thyroid-stimulating hormone (TSH): 0.35-5.0 mIU/L.
fendo-06-00123-g002.jpg
PMC4539555_01_fendo-06-00123-g002.jpg
F2
TSH level was 0.171 mIU/L and that his free thyroxine (FT4) level was 97.6 pmol/L (normal range, 9.1-23.8 pmol/L), consistent with primary hyperthyroidism (Figures 2 and 3). Technetium-99m (Tc-99m) pertechnetate scintigraphy revealed generalized reduced tracer uptake in the thyroid gland, a finding that is compatible with thyroiditis (Figure 4).
99m TcMIBI (sestamibi) dual-phase parathyroid scintigraphy revealed two foci located below the lower poles of both thyroid lobes with intact thyroid uptake compatible with parathyroid adenomas.
fendo-06-00123-g003.jpg
PMC4539555_01_fendo-06-00123-g003.jpg
F3
TSH level was 0.171 mIU/L and that his free thyroxine (FT4) level was 97.6 pmol/L (normal range, 9.1-23.8 pmol/L), consistent with primary hyperthyroidism (Figures 2 and 3). Technetium-99m (Tc-99m) pertechnetate scintigraphy revealed generalized reduced tracer uptake in the thyroid gland, a finding that is compatible with thyroiditis (Figure 4).
Technetium-99m (Tc-99m) pertechnetate scintigraphy of the patient's thyroid gland is faintly observed with generalized reduced tracer uptake in the thyroid gland. There is increased background tracer activity in the salivary glands. These findings are compatible with thyroiditis.
fendo-06-00123-g004.jpg
PMC4539555_01_fendo-06-00123-g004.jpg
F4
TSH level was 0.171 mIU/L and that his free thyroxine (FT4) level was 97.6 pmol/L (normal range, 9.1-23.8 pmol/L), consistent with primary hyperthyroidism (Figures 2 and 3). Technetium-99m (Tc-99m) pertechnetate scintigraphy revealed generalized reduced tracer uptake in the thyroid gland, a finding that is compatible with thyroiditis (Figure 4).